116 related articles for article (PubMed ID: 1888141)
1. Effect on protein synthesis and cell survival of the benzaldehyde derivatives sodium benzylidene ascorbate (SBA) and the deuterated compound zilascorb(2H).
Pettersen EO; Larsen RO; Boerretzen B; Dornish JM; Oftebro R
Anticancer Res; 1991; 11(3):1077-81. PubMed ID: 1888141
[TBL] [Abstract][Full Text] [Related]
2. In vitro modulating effect of the reversible protein synthesis inhibitor zilascorb (2H) on cis-diamminedichloroplatinum (II)-induced cytotoxicity.
Melvik JE; Dornish JM; Larsen RO; Børretzen B; Oftebro R; Pettersen EO
Anticancer Res; 1992; 12(1):33-8. PubMed ID: 1567178
[TBL] [Abstract][Full Text] [Related]
3. Induction of DNA fragmentation in human myelogenous leukemic cell lines by sodium 5,6-benzylidene-L-ascorbate and its related compounds.
Kuribayashi N; Sakagami H; Sakagami T; Niimi E; Shiokawa D; Ikekita M; Takeda M; Tanuma S
Anticancer Res; 1994; 14(3A):969-76. PubMed ID: 8074500
[TBL] [Abstract][Full Text] [Related]
4. 4,6-Benzylidene-D-glucose, a benzaldehyde derivative that inhibits protein synthesis but not mitosis of NHIK 3025 cells.
Pettersen EO; Dornish JM; Rønning OW
Cancer Res; 1985 May; 45(5):2085-91. PubMed ID: 3986764
[TBL] [Abstract][Full Text] [Related]
5. Tumour necrotisation in nude mice xenografts by the reversible protein synthesis inhibitor zilascorb(2H).
Pettersen EO; Larsen RO; Dornish JM; Børretzen B; Juul ME; Aastveit TE; Nesland JM; Rofstad EK; Oftebro R
Br J Cancer; 1993 Apr; 67(4):650-6. PubMed ID: 8471421
[TBL] [Abstract][Full Text] [Related]
6. Increased effect of benzaldehyde by exchanging the hydrogen in the formyl group with deuterium.
Pettersen EO; Larsen RO; Børretzen B; Dornish JM; Oftebro R
Anticancer Res; 1991; 11(1):369-73. PubMed ID: 2018372
[TBL] [Abstract][Full Text] [Related]
7. Stability of sodium 5,6-benzylidene-L-ascorbate.
Sakagami H; Yamamura TS; Takahashi H; Shibuya I; Takeda M
Anticancer Res; 1995; 15(4):1269-74. PubMed ID: 7654007
[TBL] [Abstract][Full Text] [Related]
8. Effect on cell survival and protein synthesis of benzylidene-glucose (BG) and the deuterated analogue P-1013 in cultured cells.
Dunsaed CB; Dornish JM; Oftebro R; Pettersen EO
Anticancer Res; 1995; 15(5B):1921-7. PubMed ID: 8572579
[TBL] [Abstract][Full Text] [Related]
9. Tumor-specific cytotoxicity and type of cell death induced by sodium 5,6-benzylidene-L-ascorbate.
Kishino K; Hashimoto K; Amano O; Kochi M; Liu WK; Sakagami H
Anticancer Res; 2008; 28(5A):2577-84. PubMed ID: 19035281
[TBL] [Abstract][Full Text] [Related]
10. Sodium 5, 6-benzylidene-L-ascorbate induces in vitro neuronal cell differentiation accompanying apoptosis and necrosis.
Tashiro F; Sugiyama A; Urano Y; Kochi M
Anticancer Res; 2002; 22(3):1423-31. PubMed ID: 12168819
[TBL] [Abstract][Full Text] [Related]
11. Interaction between sodium 5,6-benzylidene-L-ascorbate and gallic acid.
Koyama N; Satoh K; Ida Y; Hiroi M; Oi T; Kochi M; Yamamoto Y; Sakagami H
Anticancer Res; 1999; 19(2A):1159-64. PubMed ID: 10368669
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial control of cell death induction by sodium 5,6-benzylidene-L-ascorbate.
Fujii H; Amano O; Kochi M; Sakagami H
Anticancer Res; 2003; 23(2B):1353-6. PubMed ID: 12820394
[TBL] [Abstract][Full Text] [Related]
13. Ca2+ mobilization during cell death induction by sodium 5, 6-benzylidene-L-ascorbate.
Takahashi H; Sakagami H; Ohata H; Iida M; Momose K; Yamamura M; Takeda M
Anticancer Res; 1996; 16(5A):2629-34. PubMed ID: 8917362
[TBL] [Abstract][Full Text] [Related]
14. Interaction between sodium 5,6-benzylidene-L-ascorbate and dopamine.
Satoh K; Ida Y; Kochi M; Sakagami H
Anticancer Res; 1998; 18(5A):3565-9. PubMed ID: 9858940
[TBL] [Abstract][Full Text] [Related]
15. Production of hydrogen peroxide in cancerous tissue by intravenous administration of sodium 5,6-benzylidene-L-ascorbate.
Asano K; Satoh K; Hosaka M; Arakawa H; Inagaki M; Hisamitsu T; Maeda M; Kochi M; Sakagami H
Anticancer Res; 1999; 19(1A):229-36. PubMed ID: 10226547
[TBL] [Abstract][Full Text] [Related]
16. Zilascorb(2H), a low-toxicity protein synthesis inhibitor that exhibits signs of anticancer activity in malignant melanoma.
Semb KA; Aamdal S; Mette E; Ingvar C; Gullaksen N; Osmundsen K
Anticancer Drugs; 1998 Oct; 9(9):797-802. PubMed ID: 9840726
[TBL] [Abstract][Full Text] [Related]
17. Tumor-specific action of sodium 5,6-benzylidene-L-ascorbate in N-nitrosodiethylamine-administered mouse model.
Asano K; Satoh K; Kochi M; Kusama K; Sakagami H
Anticancer Res; 2001; 21(1A):281-4. PubMed ID: 11299747
[TBL] [Abstract][Full Text] [Related]
18. Role of hydrogen peroxide in cytotoxicity induction by ascorbates and other redox compounds.
Iwasaka K; Koyama N; Nogaki A; Maruyama S; Tamura A; Takano H; Takahama M; Kochi M; Satoh K; Sakagami H
Anticancer Res; 1998; 18(6A):4333-7. PubMed ID: 9891488
[TBL] [Abstract][Full Text] [Related]
19. Relationship between ascorbyl radical intensity and apoptosis-inducing activity.
Sakagami H; Satoh K; Ohata H; Takahashi H; Yoshida H; Iida M; Kuribayashi N; Sakagami T; Momose K; Takeda M
Anticancer Res; 1996; 16(5A):2635-44. PubMed ID: 8917363
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the antitumor action between sodium 5,6-benzylidene-L-ascorbate and sodium ascorbate (minireview).
Sakagami H; Satoh K; Kochi M
Anticancer Res; 1997; 17(6D):4451-2. PubMed ID: 9494548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
